Research conducted as part of UKRIs digital health technology catalyst sponsored by Healum Ltd in partnership with Vernova Healthcare CIC, demonstrates that the use of Healum’s mobile app, connected to its care planning software and patient management system for healthcare professionals in primary care, has helped to improve health outcomes, health engagement and quality of life for people living with type 2 diabetes.
Food and Drug Administration’s guidance investigators can consider telehealth visits so long as no in-person interaction is needed, FDA expects that protocol specify which visits conducted via telehealth and which require the participant to either be seen in person
On May 2, 2023, the U.S. Food and Drug Administration (FDA) released Draft Guidance regarding the implementation of Decentralized Clinical Trials (DCTs) for drugs, biological products, and devices.